Jann, Michael W.; Cohen, Lawrence J. - In: Disease Management and Health Outcomes 3 (1998) 3, pp. 115-129
Schizophrenia continues to be a major healthcare expenditure in our society. Antipsychotic drugs were introduced in the 1950s and revolutionised its treatment; however, these drugs also produced numerous adverse effects. The direct and indirect costs of schizophrenia were estimated to total...